Gaslightwala Abizer
Insider CIK 2049375 · AKTX President & CEO, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AKTX Akari Therapeutics Plc | M Exercise deriv | 2026-10-14 | 2026-10-16 | 7,733 | $16.16 | $125.0K | 0 | SEC↗ |
| AKTX Akari Therapeutics Plc | M Exercise deriv | 2026-10-14 | 2026-10-16 | 19,333 | $16.16 | $312.4K | 0 | SEC↗ |
| AKTX Akari Therapeutics Plc | M Exercise | 2026-10-14 | 2026-10-16 | 7,733 | $0.00 | $3 | 41,173 | SEC↗ |
| AKTX Akari Therapeutics Plc | M Exercise | 2026-10-14 | 2026-10-16 | 19,333 | $0.00 | $8 | 33,440 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award | 2026-09-29 | 2026-10-01 | 6,430 | $9.72 | $62.5K | 14,107 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award deriv | 2026-08-18 | 2026-10-16 | 174,000 | — | $0 | 174,000 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award deriv | 2026-06-24 | 2026-06-25 | 15,563 | — | $0 | 15,563 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award deriv | 2026-06-24 | 2026-06-25 | 5,500 | — | $0 | 5,500 | SEC↗ |
| AKTX Akari Therapeutics Plc | P Buy deriv | 2025-12-16 | 2025-12-18 | 773,323 | $0.40 | $309.3K | 773,323 | SEC↗ |
| AKTX Akari Therapeutics Plc | P Buy deriv | 2025-12-16 | 2025-12-18 | 309,328 | $0.40 | $123.7K | 309,328 | SEC↗ |
| AKTX Akari Therapeutics Plc | P Buy deriv | 2025-12-16 | 2025-12-18 | 309,328 | — | $0 | 309,328 | SEC↗ |
| AKTX Akari Therapeutics Plc | P Buy deriv | 2025-12-16 | 2025-12-18 | 773,323 | — | $0 | 773,323 | SEC↗ |
| AKTX Akari Therapeutics Plc | P Buy | 2025-08-25 | 2025-08-29 | 3,000 | $0.90 | $2.7K | 298,574 | SEC↗ |
| AKTX Akari Therapeutics Plc | P Buy | 2025-08-22 | 2025-08-29 | 8,000 | $0.93 | $7.4K | 295,574 | SEC↗ |
| AKTX Akari Therapeutics Plc | P Buy | 2025-08-21 | 2025-08-29 | 10,000 | $0.94 | $9.4K | 287,574 | SEC↗ |
| AKTX Akari Therapeutics Plc | P Buy | 2025-06-24 | 2025-06-25 | 5,203 | $1.16 | $6.0K | 277,574 | SEC↗ |
| AKTX Akari Therapeutics Plc | P Buy | 2025-06-23 | 2025-06-25 | 943 | $1.15 | $1.1K | 272,371 | SEC↗ |
| AKTX Akari Therapeutics Plc | P Buy | 2025-06-20 | 2025-06-24 | 10,000 | $1.20 | $12.0K | 271,428 | SEC↗ |
| AKTX Akari Therapeutics Plc | P Buy | 2025-06-17 | 2025-06-20 | 15,000 | $1.20 | $18.0K | 261,428 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award | 2025-06-13 | 2025-06-16 | 25,000 | $1.19 | $29.8K | 246,428 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award | 2025-06-12 | 2025-06-16 | 20,000 | $1.23 | $24.6K | 221,428 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award | 2025-06-10 | 2025-06-12 | 20,000 | $1.27 | $25.4K | 201,428 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award deriv | 2025-03-20 | 2025-03-24 | 600,000 | — | $0 | 600,000 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award deriv | 2025-03-20 | 2025-03-24 | 1,100,000 | — | $0 | 1,100,000 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award deriv | 2025-03-06 | 2025-03-10 | 133,928 | $1.12 | $150.0K | 133,928 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award deriv | 2025-03-06 | 2025-03-10 | 133,928 | $1.12 | $150.0K | 133,928 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award | 2025-03-06 | 2025-03-10 | 133,928 | $1.12 | $150.0K | 181,428 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award | 2025-01-10 | 2025-01-13 | 11,439 | $1.22 | $14.0K | 35,860 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award | 2025-01-10 | 2025-02-07 | 11,640 | $1.22 | $14.2K | 47,500 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award | 2025-01-03 | 2025-01-07 | 1,720,000 | — | $0 | 71,720,000 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award | 2024-12-27 | 2024-12-30 | 40,000,000 | — | $0 | 70,000,000 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award | 2024-12-26 | 2024-12-27 | 30,000,000 | — | $0 | 30,000,000 | SEC↗ |